Industries > Pharma > Botanical and Plant-Derived Drugs Market Forecast to 2027

Botanical and Plant-Derived Drugs Market Forecast to 2027

Prospects for Leading Companies in Steroids, Phenols, Terpenes, Glycosides and Others, Sativex, Marinol Nabilone, Dexanabinol, CT-3, Cannabinor, HU 308, HU 331, Rimonabant, Taranabant

PUBLISHED: 19 December 2017
PAGES: 164
PRODUCT CODE: PHA0270

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The global botanical and plant-derived drugs market is expected to grow at a CAGR of 6.8% in the first half of the forecast period. In 2016, the phenols submarket held 30.2% of the global botanical and plant-derived drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 70 tables and 82 figures– all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global botanical and plant-derived drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Botanical and Plant-derived Drugs Market forecast to 2027

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by type:
– Steroids
– Phenols
– Terpenes
– Glycosides
– Others

This report provides a SWOT analysis for each submarket.

Botanical and Plant-Derived Drugs Market Forecast to 2027

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by application:
– Hormone Diseases
– Infectious Diseases
– Pain & Central Nervous System Disorders
– Cardiovascular & Metabolic Diseases
– Respiratory & Oncology Diseases

• Our work also shows individual revenue forecasts to 2027 for these regional and national markets
– North America: US & Canada
– Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of APAC
– Latin America: Brazil, Mexico, Rest of Latin America
– Middle East & Africa: Saudi Arabia, South Africa, Rest of Middle East & Africa

Each regional market if further segmented by type and by application.

• This report discusses several brands, including:
– Sativex (GW Pharmaceuticals)
– Marinol (Unimed Pharmaceuticals)
– Nabilone / Cesamet (Valeant Pharmaceuticals)
– Dexanabinol (Solvay Pharmaceuticals, acquire by Abbott Laboratories)
– CT-3 (Indevus Pharmaceuticals)
– Cannabinor (Pharmos)
– HU 308 (Pharmos)
– HU 331 (Cayman Chemical)
– Rimonabant / Acomplia (Sanofi-Aventis)
– Taranabant / MK-0364 (Merck & Co.)

• This report assesses several leading companies that manufacture and market botanical and plant-derived drugs, including:
– Abbott Laboratories
– Bayer AG
– Eli Lilly
– Johnson & Johnson
– Novartis AG
– Pfizer, Inc.
– Bristol-Myers Squibb (BMS)
– Medigene AG

• This report also discusses the Drivers and Restraints of the global botanical and plat derived-drugs market.

Visiongain’s study is for everybody needing commercial analyses for the global botanical and plat derived-drugs market. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Botanical and Plant-Derived Drugs Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Botanical and Plant-Derived Drugs Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ